High-definition Transcranial Direct Current Stimulation and Chlorella Pyrenoidosa to Reduce Cardiovascular Risk

Launched by FEDERAL UNIVERSITY OF PARAÍBA · Feb 11, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a combination of two treatments—high-definition transcranial direct current stimulation (HD-tDCS) and a type of microalgae called Chlorella Pyrenoidosa—to see if they can help reduce cardiovascular risks in patients who have lingering symptoms after recovering from COVID-19. Many people who had COVID-19 report ongoing issues, including heart-related problems, and this research aims to find out if these treatments can improve vitamin B12 levels and overall heart health in these patients.

To participate in the trial, you need to be an adult between 18 and 80 years old and have a cardiovascular condition or be at risk for one, along with experiencing post-COVID symptoms. If you join, you will receive either the neurostimulation treatment or Chlorella and be monitored for how these treatments affect your health. However, there are certain exclusions, so individuals with specific health issues, such as certain heart conditions or pregnancy, cannot participate. This study is currently recruiting participants, and it’s a chance to help researchers learn more about potential treatments for those affected by long-term COVID-19 symptoms.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with cardiovascular diagnosis or risk;
• • Adults and elderly people (18 to 80 years old);
• • Able to respond to commands and grant consent to participate in the research through the informed consent form;
• • Who have post-COVID symptoms.
• Exclusion Criteria:
• • Patients with a clinical history of neuromuscular or cognitive instability, pregnancy and contraindications for receiving neurostimulation (such as cardiac pacemakers and metallic brain implants);
• • Patients with contraindications to the use of Chlorella (gastritis, esophagitis, peptic ulcers),
• • Pregnant patients, patients with stroke and tumors